|  | 
        
          |  | RISK MANAGEMENT  |  
          | Intraoperative Management |  
          |  |  |  
          | MATERNAL CO2 MONITORING |  
          | 
            End-tidal or transcutaneous CO2 monitoring can be very useful for monitoring for  intraoperative maternal complications in pregnant patients (see table at right). 
                
                  
                    
                      Intrapertioneal CO2 insufflation may increase maternal PaCO2. Although probably not severe, alterations in maternal PaCO2 levels can lead to uterine artery contraction.
 |  
          | INTRAOPERATIVE MEDICATIONS |  
          | 
            
              
                
                  
                    
                      
                        TOCOLYTICS
                          
                          
                                  
                                        
                                            
                                              
                                                Beta-agonist tocolytics are associated with maternal pulmonary edema, atrial fibrillation, chest pain, and ECG changes. [11] Magnesium may decrease platelet aggregation. 
                  
                    Ephedrine, if needed, is less likely to cause uterine artery spasm than other vasopressors.
 |  
 
 | 
        
          |  |  |  
          |  |  
          |  |  
          
         
          | Tocolytics have significant side effects - do not treat uterine contractions unless truly concerning of preterm labor. |  |  |